Welireg

Welireg (belzutifan)

Welireg

Belzutifan

Tablets: 40 mg

Merck & Co., Inc.

Medical Use

Medical Uses - WELIREG is a hypoxia-inducible factor inhibitor indicated: von Hippel-Lindau (VHL) disease, Advanced Renal Cell Carcinoma (RCC) and Pheochromocytoma or Paraganglioma (PPGL).

WhatsApp Chat